Clinical Commissioning Policy: Emicizumab as prophylaxis in people with congenital haemophilia A with factor VIII inhibitors (all ages)

Document first published:
Page updated:
Topic:
,
Publication type:

This policy document outlines the arrangements for funding of treatment for people with congenital haemophilia A with factor VIII inhibitors.